Lifevantage (LFVN) traded down -2.01 % during a 24 hours period ending at 04:54 PM Central Europe on Monday 26th. One Lifevantage stock can currently be bought for about USD 5.6 on popular exchanges. Current supply of Lifevantage stocks is 12.5 mn. Lifevantage has a current market capitalization of USD 73.4 mn and approximately USD 138.9 k worth of Lifevantage was traded on exchanges in the last 24 hours. Since last month end, Lifevantage has traded -6.84 % down. Simple moving average of last 200 days is at USD 5.9. The highest price of past 52 weeks was recorded at USD 11.71 on 06/02/2026. 52 weeks low was at USD 3.9 on 04/09/2026.
Here is how related stocks have performed in the past 24 hours:
Smith Douglas Homes (SDHC) traded up 2.96 % and now trades at USD 10.75. Current market capitalisation for Smith Douglas Homes is USD 87.6 mn.
Tenaya Therapeutics (TNYA) traded up 0.26 % and now trades at USD 0.41. Tenaya Therapeutics has a market capitalisation of USD 87.2 mn.
First Northwest (FNWB) traded flat 0 % and now trades at USD 9.78. First Northwest has a market capitalisation of USD 85.8 mn. Current price/earnings ratio for First Northwest is 57.83.
Conexeu Sciences (CNXU) traded down -6.06 % and now trades at USD 3.05. Conexeu Sciences has a market capitalisation of USD 87.4 mn.
Rani Therapeutics (RANI) traded up 3.06 % and now trades at USD 0.6. Rani Therapeutics has a market capitalisation of USD 85.1 mn.
About Lifevantage
The Lifevantage Corporation is a health and nutrition company based in Lehi, United States, which specializes in developing dietary supplements. These supplements are designed to combat oxidative stress to support brain, eye, and joint function, as well as skin canine products. The company produces a range of nutritional products aimed at maintaining good health and preventing various health issues. You can find out more about their products and services on their website www.lifevantage.com . The stock of this company is traded on the Nasdaq stock exchange.